ARCH Venture Partners X, LLC

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 10% 8.2% 15.1%
Success rate 87% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
ARCH Venture Partners X, LLC's trades of Neumora Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-29 2025-10-27
B Purchase
86,923 +32.5%
447.28
US$4,952,632 		86,923 +32.5% 447.28 US$4,952,632
2025-08-01 2025-08-01
B Purchase
57,583 +44.9%
64.18
US$1,323,177 		57,583 +44.9% 64.18 US$1,323,177
2024-02-20 2024-02-15
B Purchase
41,224 +48.6%
139.68
US$1,151,018 		41,224 +48.6% 139.68 US$1,151,018
2023-09-20 2023-09-19
B Purchase
1,500,000 +70.6%
17.00
US$25,500,000 		1,500,000 +70.6% 17.00 US$25,500,000
2023-09-20 2023-09-19
B Purchase
1,500,000 +70.6%
17.00
US$25,500,000 		1,500,000 +70.6% 17.00 US$25,500,000
2022-10-26 2022-10-24
B Purchase
400,000 +7.0%
17.00
US$6,800,000 		400,000 +7.0% 17.00 US$6,800,000
2022-10-26 2022-10-24
B Purchase
400,000 +7.0%
17.00
US$6,800,000 		400,000 +7.0% 17.00 US$6,800,000
2019-02-26 2019-02-22
B Purchase
1,865,800 +inf%
2.50
US$4,664,500 		1,865,800 +inf% 2.50 US$4,664,500
2019-02-26 2019-02-22
B Purchase
150,000 +17.0%
2.50
US$375,000 		150,000 +17.0% 2.50 US$375,000
2019-02-26 2019-02-22
B Purchase
150,000 +5.5%
2.50
US$375,000 		150,000 +5.5% 2.50 US$375,000